メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
富山大学 ホーム
日本語
English
ホーム
プロファイル
研究部門
設備
プロジェクト
研究成果
データセット
受賞
活動
授業
専門知識、名前、または所属機関で検索
消化器がん診断・治療学推進講座
富山大学
医学部
概要
フィンガープリント
ネットワーク
プロジェクト
(3)
研究成果
(113)
データセット
(8)
フィンガープリント
消化器がん診断・治療学推進講座が活動している研究トピックを掘り下げます。これらのトピックラベルは、この組織のメンバーの研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Keyphrases
Hepatocellular Carcinoma
100%
Liver
83%
Liver Fibrosis
63%
Ischemia-reperfusion Injury
52%
Hepatocyte Growth Factor
45%
Heme oxygenase-1 (HO-1)
42%
Japan
38%
Tissue Inhibitor of metalloproteinase-1 (TIMP-1)
38%
Liver Injury
38%
Fatty Liver
37%
Matrix Metalloproteinases
35%
Carbon Tetrachloride
35%
Hepatitis B Surface Antigen (HBsAg)
34%
Hepatic Stellate Cells
34%
Nonalcoholic Steatohepatitis
33%
Tumor Necrosis Factor-α
31%
Acute Liver Injury
31%
Prolyl Hydroxylase
29%
Gene Expression
29%
Stellate Cells
28%
Rat Liver
28%
Hepatocytes
27%
Liver Model
27%
Tumor
25%
Type IV Collagen
25%
Advanced Gastric Cancer
24%
Matrix metalloproteinase-2 (MMP-2)
23%
Kupffer Cells
22%
Chemotherapy
22%
Liver Cirrhosis
21%
Matrix metalloproteinase-9 (MMP-9)
21%
Hepatitis B Virus Infection
20%
Interferon-α (IFN-α)
20%
Sorafenib
20%
Transforming Growth Factor-β
20%
Growth-related Genes
20%
Hepatitis C Virus
19%
Advanced Cirrhosis
19%
Advanced Hepatocellular Carcinoma
18%
Inflammatory Cytokines
18%
Apoptosis
18%
High-fat Diet
18%
Human Hepatocellular Carcinoma
18%
Pathological Diagnosis
18%
Immunoelectron
18%
Choline-deficient
18%
Fibrosis
17%
Methionine
17%
Glycyrrhizin
17%
Chronic Hepatitis C
17%
KRAS mutation
17%
Antisense Oligonucleotides
17%
Steatohepatitis
17%
Fulminant Hepatic Failure
17%
Varicella Vaccine
17%
5-fluorouracil (5-FU)
17%
Docetaxel
17%
Percutaneous Radiofrequency Ablation
17%
Sirtuin 1 (SIRT1)
17%
Spatial Distribution
17%
Hepatitis
17%
Hepatoma Cells
17%
Signaling Pathway
16%
Hepatic Fibrosis
16%
Collagen
16%
Young Males
15%
Type I Collagen
15%
Risk Factors
15%
Steatotic Liver
15%
Chronic Hepatitis
14%
Recombinant
14%
Rough Endoplasmic Reticulum
14%
Hepatocyte Apoptosis
14%
Mouse Model
13%
Chemotherapy-induced Diarrhea
13%
Hepatectomy
13%
Nivolumab
13%
Mouse Liver
13%
Chronic Liver Disease
13%
Endoscopic Ultrasound-guided Fine-needle Aspiration (EUS-FNA)
13%
Human Hepatocytes
13%
Liver Metastasis
13%
Colorectal Cancer
13%
Overall Survival
12%
Regeneration
12%
Gastric Cancer
12%
Transplantation
12%
Cirrhotic Liver
12%
Chronic Liver Injury
12%
Tumor Growth
12%
Liver Disease
12%
Cell-to-cell
12%
Molecular Hydrogen
12%
Extracellular Matrix Protein 1 (ECM1)
12%
Electroporation
12%
Liver Function
12%
Differential Diagnosis
11%
Human Liver
11%
Adipose Tissue
11%
Index Score
11%
Medicine and Dentistry
Hepatocellular Carcinoma
84%
Liver Injury
53%
Hepatocyte
36%
Liver Cirrhosis
35%
Liver Fibrosis
34%
In Vitro
32%
Carbon Tetrachloride
31%
Hepatic Stellate Cell
31%
Neoplasm
29%
Fatty Liver
28%
Recurrent Disease
27%
Radiofrequency Ablation
26%
Cell Line
25%
Matrix Metalloproteinase
24%
Stellate Cell
24%
Fibrosis
24%
Messenger RNA
24%
Abdominal Cancer
23%
Chemotherapy
23%
Gene Expression
22%
Injury
21%
Tissue Inhibitor of Metalloproteinase 1
21%
Nonalcoholic Fatty Liver
20%
Hepatitis B
19%
Fibrinogen
18%
Collagen Type 1
18%
Interferon
17%
Fulminant Hepatic Failure
17%
Oncogene Ras
17%
Steatohepatitis
17%
Antisense Oligonucleotide
17%
Experimental Fatty Liver
17%
Reperfusion Injury
17%
Pancreatic Cancer Cell Line
17%
Kupffer Cell
17%
Liver Tumor
16%
Macrophage
16%
Methionine
16%
Choline
16%
Extracellular Matrix
15%
Programmed Cell Death
15%
Fibrogenesis
15%
Metalloprotease Inhibitor
15%
Signal Transduction
15%
Gelatinase A
15%
Chronic Hepatitis
14%
Tumor Progression
14%
Metastatic Carcinoma
14%
Chronic Liver Disease
13%
Nivolumab
13%
Liver Metastasis
13%
Hepatic Encephalopathy
13%
Ascites
12%
Heme Oxygenase 1
12%
Gelatinase B
11%
High Fat Food
11%
Low Drug Dose
11%
Inflammatory Cytokine
11%
Differential Diagnosis
11%
Collagen Type 4
11%
Cancer Growth Factor
11%
Endoscopic Ultrasound Guided Fine Needle Biopsy
11%
Procollagen Proline 2 Oxoglutarate 4 Dioxygenase
11%
Rough Endoplasmic Reticulum
11%
Adenocarcinoma
11%
Magnetic Resonance Imaging
10%
Hepatoma Cell
10%
Hepatitis C
10%
Liver Transplantation
10%
Pancreas Cancer
10%
Scatter Factor
10%
Ferrous Ion
10%
Hepatitis C Virus
10%
Laminin
10%
Diabetes Mellitus
9%
Collagen Type 3
9%
Experimental Liver Fibrosis
9%
Lymphocyte
9%
Liver Regeneration
9%
Partial Hepatectomy
9%
Docetaxel
8%
Stomach Carcinoma
8%
Multiple Myeloma
8%
Diaphragm Hernia
8%
Neutrophil
8%
Angiomyolipoma
8%
Stellate Cell Line
8%
Interstitial Lung Disease
8%
Copurification
8%
Mesenchymal-Epithelial Transition
8%
Pyrophosphate
8%
Telmisartan
8%
Hemochromatosis
8%
Liver Lobectomy
8%
Gemcitabine
8%
Acinic Cell Carcinoma
8%
Piecemeal Necrosis
8%
Dendritic Cell Function
8%
Small-Cell Carcinoma
8%
Ischemia
8%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
83%
Liver Injury
55%
Reperfusion Injury
43%
Scatter Factor
43%
Liver Fibrosis
40%
Nonalcoholic Fatty Liver
39%
Chemotherapy
38%
Matrix Metalloproteinase
34%
Fatty Liver
34%
Heme Oxygenase 1
33%
Injury
33%
Carbon Tetrachloride
27%
Tumor Necrosis Factor
27%
Procollagen Proline 2 Oxoglutarate 4 Dioxygenase
26%
Experimental Fatty Liver
26%
Liver Cirrhosis
25%
Tissue Inhibitor of Metalloproteinase
24%
Abdominal Cancer
23%
Cytokine
22%
Messenger RNA
22%
Sorafenib
20%
Choline
19%
Neoplasm
18%
Glycyrrhizin
17%
Interferon
17%
Docetaxel
17%
Hepatitis C Virus
17%
Gelatinase A
15%
Cancer Growth Factor
15%
Overall Survival
15%
Disease
14%
Combination Therapy
14%
Hepatitis B Virus
14%
Fibrinogen
14%
Recurrent Disease
14%
Tissue Inhibitor of Metalloproteinase 1
13%
Gelatinase B
13%
Fibrosis
13%
Liver Disease
13%
Diarrhea
13%
Amino Acid
13%
Hepatic Encephalopathy
13%
Infection
13%
Ascites
12%
Collagen Type 1
12%
Collagen Type 4
11%
Hepatitis B
11%
Virus Hepatitis
11%
Toxic Injury
11%
Mitogen Activated Protein Kinase
11%
Methionine
11%
Collagenase 3
11%
Hepatitis C
10%
Tumor Growth
10%
Colitis
10%
Metastasis
10%
Rat Model
10%
Ferrous Ion
10%
Fluorouracil
10%
Fluoropyrimidine
10%
Immune Checkpoint Inhibitor
10%
Transcription Factor Nrf2
10%
Antivirus Agent
10%
Antioxidant
10%
Inflammation
9%
Malignant Neoplasm
9%
Lipopolysaccharide
9%
Collagen Type 3
9%
Cisplatin
9%
Chronic Hepatitis B
9%
Gene Delivery
9%
Immunotherapy
9%
Hepatitis
9%
Ischemia
8%
Syndrome
8%
Nonhodgkin Lymphoma
8%
Hepatitis B Antigen
8%
Chronic Hepatitis C
8%
Bile Duct Carcinoma
8%
Chronic Hepatitis
8%
Tumor Necrosis
8%
Osteomalacia
8%
Adefovir Dipivoxil
8%
Liver Venoocclusive Disease
8%
Prostacyclin
8%
Hepatitis E
8%
Monotherapy
8%
Experimental Mouse
8%
Multiple Myeloma
8%
Mutant Protein
8%
Glyceraldehyde 3 Phosphate Dehydrogenase
8%
Digestive System Cancer
8%
Experimental Liver Fibrosis
8%
Telmisartan
8%
Citrullinemia Type II
8%
Ulcerative Colitis
8%
Metronidazole
8%
Tolvaptan
8%
Peritoneum Metastasis
8%
Carnitine
8%